Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Russia patents space station designed to generate artificial gravity - 2Euclid space telescope sees gorgeous cosmic cloud | Space photo of the day for Nov. 18, 2025
- 3Language Learning Applications for Voyagers
- 4Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- 5The Minimized Passage Horse: Reconsidering a Symbol for the Cutting edge Period
- Sa'ar warns German delegation: 'A Palestinian state would be a Hamas terror state'
- The Best Music Collections of the 10 years
- Israeli strikes in Gaza kill 25 people, Hamas health authority says
- Israel kidnaps PIJ terrorist in covert op. in Hamas-controlled Gaza in pursuit of Ran Gvili
- Warnings rise for U.S. as severe flu strain causes outbreaks in Canada, U.K.
- Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire
- FACT FOCUS: Trump sows confusion on number of childhood vaccinations
- Chris Noth responds to backlash after seemingly shading 'Sex and the City' costar Sarah Jessica Parker: 'It is not news'
- Style Narratives: A Survey of \Patterns and Styles Assessed\ Design
